Navigation Links
'Scaffold' Could One Day Repair Damaged Hearts
Date:11/7/2008

It's the first to match structural, mechanical properties of heart tissue, scientists say

FRIDAY, Nov. 7 (HealthDay News) -- A biological scaffold that can help repair damaged hearts and could also be used to engineer other tissues has been developed by Massachusetts Institute of Technology researchers and colleagues.

The accordion-like, honeycomb scaffold is designed to be seeded with living heart cells or stem cells in order to treat congenital heart defects or aid the recovery of tissue damaged by a heart attack. As the scaffold is gradually absorbed into the body, it leaves behind new tissue, the researchers said.

The scaffold is the first specifically created to match the structural and mechanical properties of heart tissue, giving it a number of advantages over previous scaffolds designed for heart tissue engineering, according to the MIT team.

The general approach used in creating the heart scaffold has applications for other types of engineered tissues.

"In the long term, we'd like to have a whole library of scaffolds for different tissues in need of repair," Lisa E. Freed, a principal research scientist in the Harvard-MIT Division of Health Sciences and Technology, said in an MIT news release.

Each scaffold could be tailor-made with tissue-specific structural and mechanical properties, she said.

"We're already on the way to a few other examples," Freed said.

The research was published in the Nov. 2 online edition of the journal Nature Materials.

More information

The U.S. National Heart, Lung, and Blood Institute has more about cardiac rehabilitation.



-- Robert Preidt



SOURCE: Massachusetts Institute of Technology, news release, Nov. 2, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Pediatricians Could Help Screen for Alcohol Abuse in Home
2. Could It Be? A 100 Calorie Twinkie(R)?
3. Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution
4. Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution
5. Earlier Vaccination Could Cut Whooping Cough Deaths
6. Opt out system could solve donor organ shortage, says researcher
7. LegalView Reports on Rare Traumatic Brain Injury Condition That Could Cause Complete Paralysis of A Victim
8. End of Daylight Saving Time Could Be Heart-Wrenching
9. Flu Vaccine Could Prevent 357,000 Deaths in Pandemic
10. Researchers find new chemical key that could unlock hundreds of new antibiotics
11. Tests Could Predict Benefit From Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology: